SCHEMBL2235994

SCHEMBL2235994

O=C(O)NC(CO)c1cccc(NS(=O)(=O)c2ccc(-c3ccc(F)cc3F)cc2)c1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
AVPR2 P30518 1/20 0.47
GPR27 Q9NS67 1/20 0.47
MCL1 Q07820 1/20 0.46
POLB P06746 2/20 0.43
PHGDH O43175 1/20 0.43
PTGDR2 Q9Y5Y4 1/20 0.42
SCN9A Q15858 1/20 0.41
FABP1 P07148 1/20 0.41
LIMK2 P53671 1/20 0.41
KCNA5 P22460 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
ALDH1A1 P00352 1/20 0.39
ESR1 P03372 1/20 0.39
FABP4 P15090 2/20 0.39
MAPT P10636 2/20 0.39
FABP5 Q01469 1/20 0.39
TRIM24 O15164 1/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2241347 0.88 AVPR2 (0.43) AVPR2GPR27MCL1POLBPHGDH
SCHEMBL2238392 0.88 AVPR2 (0.43) AVPR2GPR27MCL1POLBPHGDH
SCHEMBL2235893 0.88 AVPR2 (0.43) AVPR2GPR27MCL1POLBPHGDH
SCHEMBL10093401 0.86 PHGDH (0.41) AVPR2GPR27MCL1POLBPHGDH
SCHEMBL10093406 0.86 PHGDH (0.41) AVPR2GPR27MCL1POLBPHGDH
SCHEMBL13464223 0.86 AVPR2 (0.42) AVPR2GPR27MCL1POLBPHGDH
SCHEMBL20117530 0.86 L3MBTL1 (0.46) AVPR2GPR27MCL1POLBPHGDH
SCHEMBL2236007 0.85 MCL1 (0.45) AVPR2GPR27MCL1POLBPHGDH
SCHEMBL2234241 0.85 MCL1 (0.45) AVPR2GPR27MCL1POLBPHGDH
SCHEMBL2241472 0.85 MCL1 (0.45) AVPR2GPR27MCL1POLBPHGDH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2349990-B1 ARYL-PHENYL-SULFONAMIDE-PHENYLENE COMPOUNDS AND THEIR USE PIMCO 2664 LTD (GB) 2018-05-02 EP disclosed
US-8207167-B2 Aryl-phenyl-sulfonamide-phenylene compounds and their use PIMCO 2664 LIMITED (GB) 2012-06-26 US disclosed
US-20110190302-A1 Aryl-Phenyl-Sulfonamide-Phenylene Compounds and Their Use PIMCO 2664 LIMITED (GB) 2011-08-04 US disclosed
EP-2349990-A1 ARYL-PHENYL-SULFONAMIDE-PHENYLENE COMPOUNDS AND THEIR USE Pimco 2664 Limited (GB) 2011-08-03 EP disclosed
WO-2010032010-A1 ARYL-PHENYL-SULFONAMIDE-PHENYLENE COMPOUNDS AND THEIR USE PIMCO 2664 LIMITED (GB) 2010-03-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110190302-A1 Aryl-Phenyl-Sulfonamide-Phenylene Compounds and Their Use SOST, PSAP, ARSA AVPR2 4580/4885GPR27 1031/4885MCL1 407/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.